Study of first affordable test for beta thalassemia
A clinical study validates the beta thalassemia diagnostic capability of the Gazelle Hb Variant Test
Stay updated with breaking news from Clinical Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A clinical study validates the beta thalassemia diagnostic capability of the Gazelle Hb Variant Test
Watch the latest scientific webinars on SelectScience.
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) EVP Michael Crowley sold 3,000 shares of Bio-Rad Laboratories stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $336.00, for a total transaction of $1,008,000.00. Following the completion of the transaction, the executive vice president now directly owns 6,942 […]
Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digitalâ„¢ PCR During Cell and Gene Therapy Production.
Federated Hermes Inc. boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 34.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 61,728 shares of the medical research company’s stock after purchasing an additional 15,871 shares during the period. Federated Hermes […]